Hypofractionated Radiotherapy for Prostate Cancer

prostate cancer: prostate cancerDefinitive radiotherapy has long been considered one of the preferred treatment options for patients with clinically localized prostate cancer. The current standard definitive radiotherapy regimen consists of conventionally fractionated (1.8-2 Gy per fraction) intensity modulated radiation therapy (IMRT) for approximately 8-9 weeks (76-80 Gray [Gy]). Although this has been demonstrated to be efficacious, the long...